Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (48)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Arnadottir, M.
Right arrow Articles by Hultberg, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arnadottir, M.
Right arrow Articles by Hultberg, B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrology Dialysis Transplantation, Vol 14, Issue 1 142-146, Copyright © 1999 by Oxford University Press


ORIGINAL ARTICLES

Influence of haemodialysis on plasma total homocystein concentration

M Arnadottir, A Berg, J Hegbrant and B Hultberg
Division of Nephrology, Department of Medicine, National University Hospital, Reykjavik, Iceland; Department of Nephrology and Department of Clinical Chemistry, University Hospital in Lund, Lund, Sweden; Park Dialys, Gambro Group Renal Care, Lund, Sweden; Corresponding author

Background: The high prevalence of hyperhomocysteinaemia in uraemic patients is of interest because of the cardiovascular risk associated with increased plasma total homocysteine (tHcy) concentration. Treatment with folic acid lowers tHcy in haemodialysis patients, however, in most patients not to normohomocysteinaemic levels. With possible tHcy-lowering modifications in mind, we studied the influence of standard haemodialysis on tHcy. Methods: In 56 folate-loaded haemodialysis patients, tHcy and parameters of dialysis adequacy were measured. In six patients, interdialytic curves of tHcy and serum creatinine concentrations were obtained and in five patients, the amount of homocysteine (Hcy) in dialysate were determined. Results: tHcy (21.8±14.4 &mgr;mol/l) correlated significantly with Kt/ (r=0.32, P<0.05), total Kt/V (r=0.29, P<0.05), nPCR (r=0.30, P<0.05) and serum concentrations of albumin (r=0.28, P<0.05) and cobalamines (r=-0.27, P<0.05). In a multiple linear regression analysis, only serum albumin concentrations significantly predicted tHcy (r=0.34, P<0.05). During dialysis, tHcy decreased by 28% and remained constant for at least 8 h after treatment. The amount of Hcy recovered in dialysate was 63 &mgr;mol (12-158 &mgr;mol). There was no difference in tHcy between those who had residual renal function and those who had not. Conclusions: The direct relationship between tHcy and Kt/V seemed to be mediated by the serum albumin concentration. The shape of the interdialytic tHcy curve suggested facilitated Hcy removal for at least 8 h after dialysis possibly due to reduced levels of inhibitory activities against relevant enzyme(s). The dialysed amount of Hcy did not seem to contribute significantly to Hcy removal. Thus, modifications of standard dialytic regimens are not likely to be effective from a tHcy-lowering point of view whereas convective procedures such as haemofiltration or haemofiltration might be more effective. Key words: haemodialysis; homocysteine; renal failure
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
R. A. Ward
Protein-Leaking Membranes for Hemodialysis: A New Class of Membranes in Search of an Application?
J. Am. Soc. Nephrol., August 1, 2005; 16(8): 2421 - 2430.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Scholze, C. Rinder, J. Beige, R. Riezler, W. Zidek, and M. Tepel
Acetylcysteine Reduces Plasma Homocysteine Concentration and Improves Pulse Pressure and Endothelial Function in Patients With End-Stage Renal Failure
Circulation, January 27, 2004; 109(3): 369 - 374.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. S. D. Vriese, M. Langlois, D. Bernard, I. Geerolf, L. Stevens, J. R. Boelaert, M. Schurgers, and E. Matthys
Effect of dialyser membrane pore size on plasma homocysteine levels in haemodialysis patients
Nephrol. Dial. Transplant., December 1, 2003; 18(12): 2596 - 2600.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
G. Buccianti, S. Raselli, I. Baragetti, F. Bamonti, E. Corghi, C. Novembrino, C. Patrosso, F. M. Maggi, and A. L. Catapano
5-methyltetrahydrofolate restores endothelial function in uraemic patients on convective haemodialysis
Nephrol. Dial. Transplant., May 1, 2002; 17(5): 857 - 864.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. N. Friedman, A. G. Bostom, A. S. Levey, I. H. Rosenberg, J. Selhub, and A. Pierratos
Plasma Total Homocysteine Levels among Patients Undergoing Nocturnal versus Standard Hemodialysis
J. Am. Soc. Nephrol., January 1, 2002; 13(1): 265 - 268.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. A. House, G. A. Wells, J. G. Donnelly, S. P. Nadler, and P. C. Hebert
Randomized trial of high-flux vs low-flux haemodialysis: effects on homocysteine and lipids
Nephrol. Dial. Transplant., July 1, 2000; 15(7): 1029 - 1034.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.